Work

I018 TT-P34: a novel first-in-class peptide drug for treatment of Huntington’s Disease

Year: 2024

Type: conference-abstract

DOI: 10.1136/jnnp-2024-ehdn.300

Authors: Anders Dalby, Mathias Kaas Ollendorff, Johan Palmfeldt, Larry Park, Simon Molgaard

Language: English

Topic: Genetic Neurodegenerative Diseases

Subfield: Cellular and Molecular Neuroscience

Field: Neuroscience

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4402373686

Cites:

Cited by:

Related to: 10